LONDON, Sept. 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) http://www.equitycapitalmanagement.co.uk has completed a preliminary review of the HTDS business model. ECM is providing an informative report to all HTDS followers at the following link http://www.equitycapitalmanagement.co.uk/ourprojects.html
Equity Capital Management PLC, (ECM) believes that in the current economic climate there are distinct opportunities to purchase under-performing asset-rich businesses ECM business model is to target such under performing companies. ECM believes HTDS is a good target for the acquisition because it is an under-performing and undervalued company, with a great potential. ECM has not been paid in cash or stock for this report on HTDS. ECM may invoice the company for a voluntary cash payment should its report prove to be of assistance to the company.
The entire report will be posted on ECM web site: http://www.equitycapitalmanagement.co.uk/ourprojects.html
The report may also be available on www.pinksheets.com under the "FILING TAB" with the sub heading "Management Discussion and Analysis" or this direct link http://www.pinksheets.com/pink/quote/quote.jsp?symbol=htds
Disclosure
ECM is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Please read our report for complete risks and disclosures.
CONTACT: www.equitycapitalmanagement.co.uk
'/>"/>
| SOURCE Hard to Treat Diseases Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimers Immunotherapy Program and Equity Investment
2. Abaxis, Inc. to Present at the ThinkEquity Sixth Annual Growth Conference
3. Omnicell to Present at Think Equitys 6th Annual Growth Conference
4. Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders Equity
5. MassMutual Analysis: Whole Life Insurance Can Help Supply Retirement Income, Preserve Equity Portfolios During Bear Markets
6. Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured
7. Smart Ideas at the Intersection of Transportation, Health, and Equity
8. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
9. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimers Immunotherapy Program and Equity Investment
10. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
11. Lumenis Completes $15 Million Equity Financing From New and Existing Investors
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |